Celiac Disease Market Report 2026

Celiac Disease Market Overview

• Celiac Disease market size has reached to $0.78 billion in 2025 • Expected to grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Advancements In Personalized Medicine Fueling The Growth Of The Market Due To Increasing Precision In Diagnosis And Treatment • Market Trend: Development Of Targeted Immune Therapies Driving Innovation In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Celiac Disease Market?

Celiac disease is an autoimmune disorder where gluten intake causes immune damage to the small intestine, leading to malabsorption and various symptoms. It’s diagnosed through blood tests and biopsy, and the only treatment is a lifelong gluten-free diet to heal the intestine and prevent complications. The main treatments of celiac disease include infliximab, larazotide acetate, gluten-free diets, and others. Infliximab is a monoclonal antibody that suppresses inflammation by blocking tumor necrosis factor-alpha (TNF-α). It can be administered through oral and parenteral routes and is used by several end users, including hospitals, home care, and others.

What Is The Celiac Disease Market Growth Forecast?

The celiac disease market size is expected to see strong growth in the next few years. It will grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to novel drug development, gluten-free food innovation, personalized nutrition, early screening programs, microbiome research. Major trends in the forecast period include rising adoption of gluten-free diets, growth of packaged gluten-free foods, expansion of drug-based therapies, increased disease awareness and diagnosis, focus on microbiome-based treatments.

Global Celiac Disease Market Segmentation

1) By Treatment: Larazotide Acetate, Gluten Free Diet, Other Treatments 2) By Route Of Administration: Oral, Parenteral 3) By End Users: Hospitals, Homecare, Other End-Users Subsegments: 1) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy 2) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages 3) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

What Is The Driver Of The Celiac Disease Market?

The growth of personalized medicine is expected to drive the growth of the celiac disease market going forward. Personalized medicine is an approach to healthcare that customizes medical care based on an individual’s genetic profile, environment, and lifestyle. The demand for personalized medicine is rising due to the increasing availability of genetic testing, which enables more accurate diagnoses and targeted treatments tailored to individual patient needs. The growth of personalized medicine supports celiac disease treatment by allowing precise identification of genetic markers and individual immune responses, leading to more targeted and effective management strategies for each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA authorized 16 personalized therapies in 2023 targeting rare diseases, a rise compared to the 6 approved in 2022. Therefore, the growth of personalized medicine will boost the growth of the celiac disease industry.

Key Players In The Global Celiac Disease Market

Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

Global Celiac Disease Market Trends and Insights

Major companies operating in the celiac disease market are focusing on developing advanced solutions, such as anti-interleukin-15 (IL-15) antibodies, to reduce tissue damage by limiting overactive immune cell activity. Anti-interleukin-15 (IL-15) antibodies are specialized proteins that inhibit the function of the IL-15 cytokine, helping to control immune system activity and inflammation. For instance, in May 2025, Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, announced that the U.S. Food and Drug Administration had granted Fast Track status for TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody. It is an investigational monoclonal antibody developed for individuals with celiac disease who remain on a gluten-free diet. It functions by blocking interleukin-15 (IL-15), a molecule involved in triggering the immune response that leads to intestinal harm in celiac patients. The therapy is currently being tested in a Phase 2a clinical trial to evaluate its safety and how well it works.

What Are Latest Mergers And Acquisitions In The Celiac Disease Market?

In May 2025, Targeted Genomics, a US-based company focused on celiac disease genetics and wellness, partnered with OraSure Technologies to offer DTC genetic celiac disease testing. The partnership enables Targeted Genomics to collaborate with a knowledgeable industry player to enhance their efforts. It strengthens their aim to deliver genetic risk information directly to health-conscious individuals. OraSure Technologies is a US-based provider of celiac disease diagnostics.

Regional Insights

North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Celiac Disease Market?

The celiac disease market consists of revenues earned by entities by providing services such as diagnostic testing services, histopathology services, dietary consultation, nutrition counseling, and food certification. The market value includes the value of related goods sold by the service provider or included within the service offering. The celiac disease market also includes sales of gluten-free foods, diagnostic test kits, nutritional supplements, gluten detection devices, and probiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Celiac Disease Market Report 2026?

The celiac disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the celiac disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.